MR编号 | FR/H/0419/001 |
---|
药品名称 | PERIOLIMEL N4E |
---|
活性成分 | |
---|
剂型 | Emulsion for infusion |
---|
上市许可持有人 | BAXTER SAS
6 avenue Louis Pasteur
78310 Maurepas |
---|
参考成员国 - 产品名称 | France (FR) |
---|
互认成员国 - 产品名称 | - Belgium (BE)
- Luxembourg (LU)
- Ireland (IE)
- Finland (FI)
- Sweden (SE)
- Hungary (HU)
PERIOLIMEL 4 g/l nitrogén elektrolitokkal emulziós infúzió - Poland (PL)
Olimel Peri N4E - Malta (MT)
- Latvia (LV)
- Czechia (CZ)
PERIOLIMEL N4E - Lithuania (LT)
OLIMEL PERI N4E infuzinė emulsija - Cyprus (CY)
OLIMEL PERI N4E EMULSION FOR INFUSION - Bulgaria (BG)
- Slovakia (SK)
OLIMEL PERI N4E - Greece (GR)
OLIMEL - Italy (IT)
- Spain (ES)
- Austria (AT)
PeriOLIMEL 2,5 % mit Elektrolyten - Emulsion zur Infusion - United Kingdom (Northern Ireland) (XI)
- Iceland (IS)
- Netherlands (NL)
- Denmark (DK)
- Germany (DE)
Olimel Peri 2,5% E Emulsion zur Infusion - Portugal (PT)
- Slovenia (SI)
- Norway (NO)
- Estonia (EE)
- Romania (RO)
Periolimel N4E
|
---|
许可日期 | 2009/10/23 |
---|
最近更新日期 | 2025/01/06 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Non Prescription (including OTC)
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|